packageTucatinib

tucatinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Tucatinib is a HER2-blocking kinase inhibitor used to treat breast cancer, including metastatic disease. It is an approved medicine and is authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q25100690 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:tucatinib
ATC codes:L01EH03
DrugBank:DB11652
PubChem CID:51039094
Wikidata:Q25100690
formula:C26H24N8O2
molar mass:480.532 g/mol (PubChem CID 51039094)
logP:4 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown